BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30791548)

  • 1. Computer-Aided Discovery of Small Molecules Targeting the RNA Splicing Activity of hnRNP A1 in Castration-Resistant Prostate Cancer.
    Carabet LA; Leblanc E; Lallous N; Morin H; Ghaidi F; Lee J; Rennie PS; Cherkasov A
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30791548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.
    Nadiminty N; Tummala R; Liu C; Lou W; Evans CP; Gao AC
    Mol Cancer Ther; 2015 Aug; 14(8):1884-95. PubMed ID: 26056150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
    Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T
    Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hnRNP A1 Regulates Alternative Splicing of Tau Exon 10 by Targeting 3' Splice Sites.
    Liu Y; Kim D; Choi N; Oh J; Ha J; Zhou J; Zheng X; Shen H
    Cells; 2020 Apr; 9(4):. PubMed ID: 32290247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer.
    Capaia M; Granata I; Guarracino M; Petretto A; Inglese E; Cattrini C; Ferrari N; Boccardo F; Barboro P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
    Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance.
    Kohli M; Ho Y; Hillman DW; Van Etten JL; Henzler C; Yang R; Sperger JM; Li Y; Tseng E; Hon T; Clark T; Tan W; Carlson RE; Wang L; Sicotte H; Thai H; Jimenez R; Huang H; Vedell PT; Eckloff BW; Quevedo JF; Pitot HC; Costello BA; Jen J; Wieben ED; Silverstein KAT; Lang JM; Wang L; Dehm SM
    Clin Cancer Res; 2017 Aug; 23(16):4704-4715. PubMed ID: 28473535
    [No Abstract]   [Full Text] [Related]  

  • 8. microRNA-mediated regulation of splicing factors SRSF1, SRSF2 and hnRNP A1 in context of their alternatively spliced 3'UTRs.
    Sokół E; Kędzierska H; Czubaty A; Rybicka B; Rodzik K; Tański Z; Bogusławska J; Piekiełko-Witkowska A
    Exp Cell Res; 2018 Feb; 363(2):208-217. PubMed ID: 29331391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hnRNP A1 dysfunction alters RNA splicing and drives neurodegeneration in multiple sclerosis (MS).
    Salapa HE; Thibault PA; Libner CD; Ding Y; Clarke JWE; Denomy C; Hutchinson C; Abidullah HM; Austin Hammond S; Pastushok L; Vizeacoumar FS; Levin MC
    Nat Commun; 2024 Jan; 15(1):356. PubMed ID: 38191621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth.
    Szafran AT; Stephan C; Bolt M; Mancini MG; Marcelli M; Mancini MA
    Prostate; 2017 Jan; 77(1):82-93. PubMed ID: 27699828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of androgen receptor splice variant AR3 by PCGEM1.
    Zhang Z; Zhou N; Huang J; Ho TT; Zhu Z; Qiu Z; Zhou X; Bai C; Wu F; Xu M; Mo YY
    Oncotarget; 2016 Mar; 7(13):15481-91. PubMed ID: 26848868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.
    Moon SJ; Jeong BC; Kim HJ; Lim JE; Kwon GY; Kim JH
    Oncogene; 2018 Mar; 37(10):1326-1339. PubMed ID: 29249800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
    McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
    Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54.
    Yang Z; Chang YJ; Miyamoto H; Yeh S; Yao JL; di Sant'Agnese PA; Tsai MY; Chang C
    Endocrinology; 2007 Mar; 148(3):1340-9. PubMed ID: 17110431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells.
    Liu L; Lou N; Li X; Xu G; Ruan H; Xiao W; Qiu B; Bao L; Yuan C; Huang X; Wang K; Cao Q; Chen K; Yang H; Zhang X
    Oncol Rep; 2017 Jun; 37(6):3651-3659. PubMed ID: 28498452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer.
    Chen CY; Jan CI; Pi WC; Wang WL; Yang PC; Wang TH; Karni R; Wang TC
    Oncotarget; 2016 Mar; 7(13):16760-72. PubMed ID: 26919236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandem hnRNP A1 RNA recognition motifs act in concert to repress the splicing of survival motor neuron exon 7.
    Beusch I; Barraud P; Moursy A; Cléry A; Allain FH
    Elife; 2017 Jun; 6():. PubMed ID: 28650318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.
    Liu L; Dong X
    PLoS One; 2014; 9(10):e108780. PubMed ID: 25360799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking of an intronic splicing silencer completely rescues IKBKAP exon 20 splicing in familial dysautonomia patient cells.
    Bruun GH; Bang JMV; Christensen LL; Brøner S; Petersen USS; Guerra B; Grønning AGB; Doktor TK; Andresen BS
    Nucleic Acids Res; 2018 Sep; 46(15):7938-7952. PubMed ID: 29762696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of CTC AR-V7 PCR assay and evaluation of its role in castration resistant prostate cancer progression.
    Tommasi S; Pilato B; Carella C; Lasorella A; Danza K; Vallini I; De Summa S; Naglieri E
    Prostate; 2019 Jan; 79(1):54-61. PubMed ID: 30141201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.